Dr. Herrmann has received institutional research funding from Abbott, Boston Scientific, Edwards Lifesciences, Highlife, Innovalve, and Medtronic; has received consultant fees from Abbott, Edwards Lifesciences, Johnson and Johnson, Medtronic, Prolifagen, Truffle Capital, Wells Fargo; and has equity in Microinterventional Devices and Holistick Medical. Dr. Chen has received consulting fees from the Cardiovascular Research Foundation. The remaining authors have no relationships relevant to the